Cargando…
Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis
Visual deficits are among the most prevalent symptoms in patients with multiple sclerosis (MS). To understand deficits in the visual pathway during MS and potential treatment effects, we used experimental autoimmune encephalomyelitis (EAE), the most commonly used animal model of MS. The afferent vis...
Autores principales: | Sekyi, Maria T., Lauderdale, Kelli, Atkinson, Kelley C., Golestany, Batis, Karim, Hawra, Feri, Micah, Soto, Joselyn S., Diaz, Cobi, Kim, Sung Hoon, Cilluffo, Marianne, Nusinowitz, Steven, Katzenellenbogen, John A., Tiwari‐Woodruff, Seema K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018057/ https://www.ncbi.nlm.nih.gov/pubmed/33368801 http://dx.doi.org/10.1111/bpa.12930 |
Ejemplares similares
-
Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis
por: Karim, Hawra, et al.
Publicado: (2019) -
Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model
of Multiple Sclerosis
por: Dupree, Jeffrey L., et al.
Publicado: (2022) -
Increase in chemokine CXCL1 by ERβ ligand treatment is a key mediator in promoting axon myelination
por: Karim, Hawra, et al.
Publicado: (2018) -
Oestrogen receptor β ligand: a novel treatment to enhance endogenous functional remyelination
por: Crawford, Daniel K., et al.
Publicado: (2010) -
The complexities of investigating mitochondria dynamics in multiple sclerosis and mouse models of MS
por: Atkinson, Kelley C., et al.
Publicado: (2023)